002562 Stock Overview
Engages in the research and development, production, and sale of leather chemicals in China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 0/6 |
Brother Enterprises Holding Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.57 |
52 Week High | CN¥4.40 |
52 Week Low | CN¥2.51 |
Beta | 0.35 |
11 Month Change | 7.21% |
3 Month Change | -7.27% |
1 Year Change | -17.55% |
33 Year Change | -3.51% |
5 Year Change | -29.03% |
Change since IPO | -20.67% |
Recent News & Updates
Shareholder Returns
002562 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 9.8% | 0.6% | 0.8% |
1Y | -17.6% | -28.3% | -21.0% |
Return vs Industry: 002562 exceeded the CN Chemicals industry which returned -28.3% over the past year.
Return vs Market: 002562 exceeded the CN Market which returned -21% over the past year.
Price Volatility
002562 volatility | |
---|---|
002562 Average Weekly Movement | 8.1% |
Chemicals Industry Average Movement | 5.7% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 002562 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002562's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 3,052 | Jianping Li | www.brother.com.cn |
Brother Enterprises Holding Co.,Ltd. engages in the research and development, production, and sale of leather chemicals in China and internationally. It operates in six segments: Vitamins, Spices, Active Pharmaceutical Ingredients, Leather Chemicals, Chrome Salt, and Catalyst.
Brother Enterprises Holding Co.,Ltd. Fundamentals Summary
002562 fundamental statistics | |
---|---|
Market cap | CN¥3.80b |
Earnings (TTM) | -CN¥211.39m |
Revenue (TTM) | CN¥2.97b |
1.3x
P/S Ratio-18.0x
P/E RatioIs 002562 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002562 income statement (TTM) | |
---|---|
Revenue | CN¥2.97b |
Cost of Revenue | CN¥2.71b |
Gross Profit | CN¥255.13m |
Other Expenses | CN¥466.52m |
Earnings | -CN¥211.39m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | -0.20 |
Gross Margin | 8.60% |
Net Profit Margin | -7.13% |
Debt/Equity Ratio | 58.1% |
How did 002562 perform over the long term?
See historical performance and comparison